{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T14:28:26Z","timestamp":1768919306125,"version":"3.49.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"FONDECYT","award":["#11085034"],"award-info":[{"award-number":["#11085034"]}]},{"name":"FONDECYT","award":["PBCT PSD-34"],"award-info":[{"award-number":["PBCT PSD-34"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.jhep.2011.02.020","type":"journal-article","created":{"date-parts":[[2011,2,27]],"date-time":"2011-02-27T14:15:10Z","timestamp":1298816110000},"page":"1112-1120","source":"Crossref","is-referenced-by-count":72,"title":["Intravenous administration of multipotent stromal cells prevents the onset of non-alcoholic steatohepatitis in obese mice with metabolic syndrome"],"prefix":"10.1016","volume":"55","author":[{"given":"Marcelo","family":"Ezquer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Ezquer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Micaela","family":"Ricca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolina","family":"Allers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulette","family":"Conget","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2011.02.020_b0005","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.cld.2007.02.013","article-title":"Metabolic syndrome and NASH","volume":"11","author":"Marchesini","year":"2007","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jhep.2011.02.020_b0010","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1067\/S0022-3476(03)00325-1","article-title":"Obesity, insulin resistance, and other clinicopathological correlates of pediatric nonalcoholic fatty liver disease","volume":"143","author":"Schwimmer","year":"2003","journal-title":"J Pediatr"},{"key":"10.1016\/j.jhep.2011.02.020_b0015","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.molmed.2007.12.003","article-title":"Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis","volume":"14","author":"Marra","year":"2008","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.jhep.2011.02.020_b0020","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1002\/hep.20973","article-title":"Nonalcoholic fatty liver disease: from steatosis to cirrhosis","volume":"43","author":"Farrell","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2011.02.020_b0025","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1111\/j.1572-0241.2003.07659.x","article-title":"The natural history of nonalcoholic fatty liver disease: a clinical histopathological study","volume":"98","author":"Harrison","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2011.02.020_b0030","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1007\/s10620-009-1081-0","article-title":"Nonalcoholic fatty liver disease: a review and update","volume":"55","author":"Lewis","year":"2010","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhep.2011.02.020_b0035","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1172\/JCI24282","article-title":"Liver fibrosis","volume":"115","author":"Bataller","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2011.02.020_b0040","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.jhep.2004.02.013","article-title":"The spectrum expanded: cryptogenic cirrhosis and the natural history of non-alcoholic fatty liver disease","volume":"40","author":"Caldwell","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2011.02.020_b0045","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S0168-8278(02)00099-5","article-title":"Hepatocellular carcinoma in patients with non-alcoholic steatohepatitis","volume":"37","author":"Shimada","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2011.02.020_b0050","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/j.1478-3231.2010.02264.x","article-title":"The challenge of developing novel pharmacological therapies for non-alcoholic steatohepatitis","volume":"30","author":"Schuppan","year":"2010","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2011.02.020_b0055","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/j.1365-2036.2007.03246.x","article-title":"GI epidemiology: nonalcoholic fatty liver disease","volume":"25","author":"Angulo","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2011.02.020_b0060","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/lt.20738","article-title":"Nonalcoholic fatty liver disease and liver transplantation","volume":"12","author":"Angulo","year":"2006","journal-title":"Liver transpl"},{"key":"10.1016\/j.jhep.2011.02.020_b0065","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1002\/lt.20435","article-title":"Fulminant hepatic failure","volume":"11","author":"Sass","year":"2005","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2011.02.020_b0070","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1136\/gut.2006.098442","article-title":"Bone marrow stem cells and liver disease","volume":"56","author":"Kallis","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2011.02.020_b0075","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s12015-006-0009-8","article-title":"The role of stem cells in physiology, pathophysiology, and therapy of the liver","volume":"2","author":"Sharma","year":"2006","journal-title":"Stem Cell Rev"},{"key":"10.1016\/j.jhep.2011.02.020_b0080","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/(SICI)1097-4652(199910)181:1<67::AID-JCP7>3.0.CO;2-C","article-title":"Phenotypical and functional properties of human bone marrow mesenchymal progenitor cells","volume":"181","author":"Conget","year":"1999","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.jhep.2011.02.020_b0085","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1016\/j.yexcr.2006.03.019","article-title":"Immune modulation by mesenchymal stem cells","volume":"312","author":"Rasmusson","year":"2006","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.jhep.2011.02.020_b0090","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1053\/j.gastro.2008.03.015","article-title":"Stem cell therapy for liver disease: parameters governing the success of using bone marrow mesenchymal stem cells","volume":"134","author":"Kuo","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2011.02.020_b0095","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1089\/scd.2010.0093","article-title":"Human mesenchymal stem cells efficiently manage oxidative stress","volume":"19","author":"Valle-Prieto","year":"2010","journal-title":"Stem Cells Dev"},{"key":"10.1016\/j.jhep.2011.02.020_b0100","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.bbrc.2007.05.150","article-title":"Immunomodulation of activated hepatic stellate cells by mesenchymal stem cells","volume":"363","author":"Parekkadan","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jhep.2011.02.020_b0105","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1182\/blood-2005-02-0572","article-title":"Human mesenchymal stem cells xenografted directly to rat liver are differentiated into human hepatocytes without fusion","volume":"106","author":"Sato","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jhep.2011.02.020_b0110","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1002\/jcb.20886","article-title":"Mesenchymal stem cells as trophic mediators","volume":"98","author":"Caplan","year":"2006","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.jhep.2011.02.020_b0115","doi-asserted-by":"crossref","first-page":"2896","DOI":"10.1634\/stemcells.2007-0637","article-title":"Concise review: mesenchymal stem\/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair \u2013 current views","volume":"25","author":"Phinney","year":"2007","journal-title":"Stem Cells"},{"key":"10.1016\/j.jhep.2011.02.020_b0120","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1038\/oby.2007.238","article-title":"C57BL\/6J and A\/J mice fed a high-fat diet delineate components of metabolic syndrome","volume":"15","author":"Gallou-Kabani","year":"2007","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.jhep.2011.02.020_b0125","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1872-034X.2007.00008.x","article-title":"Longitudinal analysis of murine steatohepatitis model induced by chronic exposure to high-fat diet","volume":"37","author":"Ito","year":"2007","journal-title":"Hepatol Res"},{"key":"10.1016\/j.jhep.2011.02.020_b0130","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1139\/o59-099","article-title":"A rapid method of total lipid extraction and purification","volume":"37","author":"Bligh","year":"1959","journal-title":"Can J Biochem Physiol"},{"key":"10.1016\/j.jhep.2011.02.020_b0135","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","article-title":"Analyzing real-time PCR data by the comparative C(T) method","volume":"3","author":"Schmittgen","year":"2008","journal-title":"Nat Protoc"},{"key":"10.1016\/j.jhep.2011.02.020_b0140","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jhep.2011.02.020_b0145","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/CJI.0b013e3181635e7f","article-title":"Migration patterns of nonspecifically activated versus nonactivated nonhuman primate T lymphocytes: preferential homing of activated autologous CD8+ T cells in the rectal mucosa","volume":"31","author":"Allers","year":"2008","journal-title":"J Immunother"},{"key":"10.1016\/j.jhep.2011.02.020_b0150","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/j.bbmt.2009.07.022","article-title":"Endovenous administration of bone-marrow-derived multipotent mesenchymal stromal cells prevents renal failure in diabetic mice","volume":"15","author":"Ezquer","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jhep.2011.02.020_b0155","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.cld.2007.02.011","article-title":"Pathogenesis of non-alcoholic steatohepatitis: human data","volume":"11","author":"Edmison","year":"2007","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jhep.2011.02.020_b0160","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1002\/hep.23594","article-title":"Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection","volume":"51","author":"Starley","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2011.02.020_b0165","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1681\/ASN.V12122625","article-title":"Bone marrow is a reservoir of repopulating mesangial cells during glomerular remodeling","volume":"12","author":"Ito","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jhep.2011.02.020_b0170","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.cld.2007.02.010","article-title":"Pathogenesis of NASH: animal models","volume":"11","author":"London","year":"2007","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jhep.2011.02.020_b0175","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.jhep.2007.08.005","article-title":"Omega 3\u2013Omega 6: what is right for the liver?","volume":"47","author":"El-Badry","year":"2007","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2011.02.020_b0180","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.jhep.2005.07.032","article-title":"Mouse livers with macrosteatosis are more susceptible to normothermic ischemic injury than those with microsteatosis","volume":"44","author":"Selzner","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2011.02.020_b0185","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1053\/jhep.2003.50048","article-title":"Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease","volume":"37","author":"Li","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2011.02.020_b0190","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/01.TP.0000128334.93343.B3","article-title":"Dynamic of distribution of human bone marrow-derived mesenchymal stem cells after transplantation into adult unconditioned mice","volume":"78","author":"Allers","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2011.02.020_b0195","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/path.2469","article-title":"Why are MSCs therapeutic? New data: new insight","volume":"217","author":"Caplan","year":"2009","journal-title":"J Pathol"},{"key":"10.1016\/j.jhep.2011.02.020_b0200","doi-asserted-by":"crossref","first-page":"F31","DOI":"10.1152\/ajprenal.00007.2005","article-title":"Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms","volume":"289","author":"Togel","year":"2005","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.jhep.2011.02.020_b0205","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1002\/hep.22236","article-title":"Mesenchymal stem cell-derived molecules directly modulate hepatocellular death and regeneration in vitro and in vivo","volume":"47","author":"van","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2011.02.020_b0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BJ20071570","article-title":"Liver fibrosis","volume":"411","author":"Wallace","year":"2008","journal-title":"Biochem J"},{"key":"10.1016\/j.jhep.2011.02.020_b0215","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1136\/gut.2003.024935","article-title":"Cytokines and the pathogenesis of non-alcoholic steatohepatitis","volume":"54","author":"Diehl","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2011.02.020_b0220","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.clinbiochem.2007.04.017","article-title":"Therapeutic potential of bone marrow-derived mesenchymal stem cells on experimental liver fibrosis","volume":"40","author":"bdel Aziz","year":"2007","journal-title":"Clin Biochem"},{"key":"10.1016\/j.jhep.2011.02.020_b0225","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/hep.21477","article-title":"Bone marrow-derived cells express matrix metalloproteinases and contribute to regression of liver fibrosis in mice","volume":"45","author":"Higashiyama","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2011.02.020_b0230","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1136\/gut.2006.111617","article-title":"Human mesenchymal stem cells as a two-edged sword in hepatic regenerative medicine: engraftment and hepatocyte differentiation versus profibrogenic potential","volume":"57","author":"di Bonzo","year":"2008","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2011.02.020_b0235","doi-asserted-by":"crossref","DOI":"10.1634\/stemcells.2007-0941","article-title":"Bone marrow multipotent mesenchymal stromal cells do not reduce fibrosis or improve function in a rat model of severe chronic liver injury","author":"Carvalho","year":"2008","journal-title":"Stem Cells"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827811002066?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827811002066?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T16:03:21Z","timestamp":1637337801000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827811002066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":47,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S0168827811002066"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2011.02.020","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}